CapsoVision Inc. recently announced the full U.S. launch of CapsoCloud, an exam management system that allows physicians to extract exam data from the CapsoCam Plus small bowel capsule endoscope system without the need to process capsules post-ingestion.
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego, will feature advances in cancer research, including reports from phase II and III clinical trials. Studies that examine innovative treatments, such as immunotherapy, mental health influences on cancer outcomes, and optimal radiation dosing and sequencing, will also be presented at the largest meeting for the field of radiation oncology.
September 13, 2017 — Since announcing the integration of CareSelect Imaging with Epic's enterprise electronic health ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
September 13, 2017 — ClaroNav announced that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance to ...
Nuance Communications Inc. announced that Citizens Medical Center, a critical access hospital in rural Kansas, has completed a hospital-wide deployment of Nuance solutions to reduce transcription costs and improve physician satisfaction, productivity and efficiency. The implementation includes Dragon Medical One, eScription RH, PowerMic Mobile and the PowerShare Network.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for pulmonary nodules. Matrix Analytics has already developed technology for the management of pulmonary nodules. This technology, leveraged with cloud computing and deep learning, will begin clinical validation later this month. The new tool applies an automated cancer classifier identified in conventional chest computed tomography (CT) images to LungDirect's advanced learning algorithms.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from Sept. 11 – 14, 2017, applying advanced technologies and deep clinical insights to address peripheral vascular needs. With the addition of its recent acquisition, Spectranetics, Philips will for the first time highlight its expanded portfolio of interventional X-ray systems, advanced catheters for measurement and therapy, clinical informatics and services, including its Philips Azurion image-guided therapy platform, intravascular ultrasound (IVUS), Phoenix atherectomy system and Spectranetics' Stellarex drug-coated balloon.
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALCON ...
The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) voted overwhelmingly last week to recommend new labels on gadolinium-based contrast agents (GBCAs) warning of the possibility of gadolinium retention in the body following administration. The labels will further explain that linear GBCAs carry a greater risk than macrocyclic agents, and that there is a greater risk for certain patient populations, according to Medscape.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
September 12, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced it has earned a new 10-year contract with a maximum ...
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by DenseBreast-info.org.
September 12, 2017 — The American Society of Radiologic Technologists (ASRT) announced it will donate $10,000 to the ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
September 12, 2017 — Using computed tomography (CT) to evaluate muscle health may help identify optimal treatments for ...
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens Somatom Force computed tomography (CT) scanner. The Somatom Force allows radiologists to obtain higher-quality images faster, more efficiently and with less radiation than older-generation CT scanners.
September 11, 2017 — Innovatus Imaging Corp., a newly created holding company formed by private equity firm Resilience ...
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women underlines the need for compression guidelines. The study confirms a number of other studies indicating that a force-standardized protocol leads to large variations in compression practices. This has serious negative effects on patient experience and the efficacy of mammography. Therefore, pressure-guided mammography with the Sigma Paddle, which is taking breast size into account, may lead to improved test results and less unnecessary discomfort and pain especially for Asian women.
Canadian-based Intronix Technologies will be working with Roy Eagleson, Ph.D., professor in the Department of Biomedical Engineering and Software Engineering at Western University, to develop new medical simulations to support treatment delivery to patients with musculoskeletal disorders.
Konica Minolta will highlight its Exa Enterprise Imaging platform at the 2017 annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its next-generation oncology information system (OIS), RayCare.
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued Interventional Procedure Guidance (IPG) supporting the use of a hydrogel barrier to reduce the risk of toxicity to surrounding tissue in radiotherapy to treat prostate cancer. The guidance recommends use of hydrogel spacers under "standard arrangements". For a procedure to be recommended for use with standard arrangements (previously called “normal arrangements”), the evidence should be adequate to show safety and efficacy of the procedure both in the long term and short term. NICE’s guidance clearly indicates that this procedure meets the highest evidence standards.